Loading company…
ScieHome develops interventional ultrasound devices and drug-device technologies for clinical use.
Founded in 2022 and based in Shanghai, China, ScieHome develops medical devices using interventional ultrasound and drug-device combination technologies. Its first core product is an ultrasound-assisted thrombolysis system in the registration clinical stage. In May 2026, the company raised Series A funding from Efung Capital. The funds are intended to accelerate commercialization and develop its ultrasound technology and product platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in